Correcting Naldemedine (Symproic) Product Summary.
作者信息
Cataldo Marc
机构信息
Director, Clinical Communications, Purdue Pharma L.P., Stamford, Connecticut.
出版信息
P T. 2017 Nov;42(11):683.
Abstract
摘要
相似文献
1
Correcting Naldemedine (Symproic) Product Summary.校正纳地美定（Symproic）产品说明书。
P T. 2017 Nov;42(11):683.
2
Naldemedine (Symproic) for the Treatment Of Opioid-Induced Constipation.纳洛酮（Symproic）用于治疗阿片类药物引起的便秘。
P T. 2018 Oct;43(10):601-627.
3
Pharmaceutical Approval Update.药品批准更新
P T. 2017 Aug;42(8):502-504.
4
A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy.纳地美定治疗接受阿片类药物治疗的慢性非癌性疼痛患者阿片类药物引起的便秘的安全性和有效性的肾功能损害亚组分析。
J Pain Res. 2020 Mar 24;13:605-612. doi: 10.2147/JPR.S237833. eCollection 2020.
5
Safety and efficacy of naldemedine in cancer patients with opioid-induced constipation: a pooled, subgroup analysis of two randomised controlled studies.纳地美定用于阿片类药物引起便秘的癌症患者的安全性和有效性：两项随机对照研究的汇总亚组分析
ESMO Open. 2019 Jul 31;4(4):e000527. doi: 10.1136/esmoopen-2019-000527. eCollection 2019.
6
Update on the role of naldemedine in opioid-induced constipation in patients with chronic noncancer pain.纳地美定在慢性非癌性疼痛患者阿片类药物所致便秘中作用的最新进展
Therap Adv Gastroenterol. 2022 Apr 28;15:17562848221078638. doi: 10.1177/17562848221078638. eCollection 2022.
7
Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies.纳地美定用于日本阿片类药物引起的便秘和慢性非癌性疼痛患者：开放标签III期研究。
J Pain Res. 2018 Dec 24;12:127-138. doi: 10.2147/JPR.S175900. eCollection 2019.
8
Opioids for pain.用于止痛的阿片类药物。
Med Lett Drugs Ther. 2018 Apr 9;60(1544):57-64.
9
Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies.在COMPOSE 3期研究中，纳地美定改善了慢性非癌性疼痛患者阿片类药物所致便秘的患者报告结局。
J Pain Res. 2021 Jul 16;14:2179-2189. doi: 10.2147/JPR.S282738. eCollection 2021.
10
Schedules of Controlled Substances: Removal of Naldemedine From Control. Final rule.《管制物质清单：将纳地美定从管制清单中移除。最终规则》
Fed Regist. 2017 Sep 29;82(188):45436-8.
本文引用的文献
1
Schedules of Controlled Substances: Removal of Naldemedine From Control. Final rule.《管制物质清单：将纳地美定从管制清单中移除。最终规则》
Fed Regist. 2017 Sep 29;82(188):45436-8.
2
Pharmaceutical Approval Update.药品批准更新
P T. 2017 Aug;42(8):502-504.
Zotero 插件